Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib in combination with chemotherapy for advanced ovarian cancer
NCT03393507Phase 2Unknown
- Sponsor
- Leshan People's Hospital
- Start
- Aug 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Rivoceranib in ovarian cancer, fallopian tube cancer (PFTC), sponsored by Leshan People's Hospital. Status: unknown.
02
Drugs
Rivoceranib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT03393507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03393507.